The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma.
Saved in:
| Title: | The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma. |
|---|---|
| Authors: | Nagata, Hiroaki1 (AUTHOR), Tsukamoto, Taku1 (AUTHOR) ttsuka@koto.kpu-m.ac.jp, Kobayashi, Tsutomu2 (AUTHOR), Takahashi, Ryoichi3 (AUTHOR), Okano, Akira3 (AUTHOR), Uchiyama, Hitoji2 (AUTHOR), Kawata, Eri4,5 (AUTHOR), Uoshima, Nobuhiko5 (AUTHOR), Kaneko, Hiroto6 (AUTHOR), Fuchida, Shin-ichi7 (AUTHOR), Nishiyama, Daichi8 (AUTHOR), Nakao, Mitsushige9 (AUTHOR), Fujino, Takahiro1 (AUTHOR), Mizutani, Shinsuke1 (AUTHOR), Shimura, Yuji1 (AUTHOR), Kuroda, Junya1 (AUTHOR) junkuro@koto.kpu-m.ac.jp |
| Source: | International Journal of Clinical Oncology. Mar2025, Vol. 30 Issue 3, p593-603. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
